Access cutting-edge hidradenitis suppurativa treatment through this clinical trial at a research site in North Little Rock. Study-provided care at no cost to qualified participants.
Access hidradenitis suppurativa specialists in North Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hidradenitis suppurativa treatment provided free
The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this hidradenitis suppurativa clinical trial in North Little Rock, AR
If you're searching for hidradenitis suppurativa treatment options in North Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our North Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.